NeuroPath Biosciences is building the world's first multimodal diagnostic platform for mental health triage combining objective biological biomarkers with a short digital behavioural check-in and agentic AI to give GPs an objective signal they can act on.

Our platform identifies the early biological changes that often precede anxiety, depression, and self-harming behaviour, giving clinicians an objective, evidence-based signal where today there is only subjective judgement.

How NeuroPath Works